RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment. (2016)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/oncsis.2016.57
PubMed Identifier: 27526106
Publication URI: http://europepmc.org/abstract/MED/27526106
Type: Journal Article/Review
Volume: 5
Parent Publication: Oncogenesis
Issue: 8
ISSN: 2157-9024